Skip to main content
2024 Guide to Patient Support Services

Helsinn Therapeutics

2024 PSS Guide

Helsinn Cares Patient Support Services

Helsinn Therapeutics offers the Helsinn Cares program that supports access, reimbursement, and assistance for patients who are prescribed a Helsinn Therapeutics oncology medication (Table).

Helsinn Cares Services

Akynzeo Capsule Savings Card

Patients with private insurance may pay as little as $0 copay through the Akynzeo Savings Program. No active enrollment or activation is required, simply download a preactivated savings card at AKYNZEOsavingsprogram.com.

Akynzeo Patient Assistance Program

Helsinn may be able to help eligible patients pay for Akynzeo through the Patient Assistance Program.

To enroll your patient in the Akynzeo Patient Assistance Program, call 844-357-4668 or visit Akynzeo Patient Assistance Program.

Valchlor Support Program

When you enroll your patient in Valchlor Support, a reimbursement specialist can help determine patient eligibility for financial assistance through the Valchlor Copay Program or a referral to patient assistance programs.

Valchlor Copay Program

Patients with private insurance who are prescribed Valchlor may be eligible for a $0 copay for each prescription fill of Valchlor through Valchlor Support.

Terms and conditions may apply..

For more information or to enroll in Valchlor Support, call 855-482-5245.

TABLE Helsinn Oncology Supportive Care Drugs

Drugs
Indications
Patient support programs

Drug
Akynzeo (netupitant and palonosetron) capsules
Indications
In combination with dexamethasone in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeated use of chemotherapy, including emetogenic agents
Patient support program

Drug
Akynzeo (fosnetupitant and palonosetron) injection
Indications
In combination with dexamethasone in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy
Patient support program

Drug
Valchlor (mechlorethamine) gel
Indications
Topical treatment of stage IA/IB mycosis fungoides–type cutaneous T-cell lymphoma after skin-directed therapy
Patient support programs